Butterfly Network (BFLY) vs NovoCure (NVCR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Butterfly Network (BFLY) has outperformed NovoCure (NVCR) over the past year, gaining 230.8% versus a gain of 3.5%. Over five years, BFLY leads with a -22.3% price change compared with -86.9% for NVCR. Butterfly Network is the larger company by market cap ($2.20 billion vs $1.71 billion), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BFLY | NVCR |
|---|---|---|
| Share price | $8.27 | $14.66 |
| Market cap | $2.20B | $1.71B |
| 1-day change | -4.94% | -2.07% |
| YTD return | +117.63% | +13.38% |
| 1-year return | +230.80% | +3.53% |
| 5-year return | -22.27% | -86.94% |
| EPS (TTM) | $-0.29 | $-1.30 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.21 | $21.45 |
| 52-week low | $1.90 | $9.82 |
| Distance from 52-week high | -19.00% | -31.66% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +37.85% | +83.22% |
| Average volume | 6.24M | 1.42M |
| Shares outstanding | 244.86M | 116.45M |
| Employees | 220 | 1,605 |
| Sector | Health Care | Health Care |
| Industry | Medical Electronics | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BFLY has outperformed NVCR by 227.3 percentage points over the past year.
About Butterfly Network
BFLY stock →Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally.
Health Care · Medical Electronics · 220 employees
About NovoCure
NVCR stock →NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax.
Health Care · Medical/Dental Instruments · 1,605 employees
BFLY vs NVCR FAQ
Which is bigger, Butterfly Network or NovoCure?
Butterfly Network (BFLY) is larger, with a market capitalization of $2.20B compared with $1.71B for NovoCure (NVCR).
Which stock has performed better over the past year, BFLY or NVCR?
BFLY returned +230.80% over the past 12 months, compared with +3.53% for NVCR (price return, excluding dividends). Past performance does not predict future results.
Are Butterfly Network and NovoCure in the same industry?
Both are in the Health Care sector, but in different industries: Medical Electronics for Butterfly Network and Medical/Dental Instruments for NovoCure.